 |
인쇄하기
취소
|
Novartis's Zelmac to be released soon
Zelmac, a drug used to treat irritable bowel syndrome, will be on the market shortly, according to Novartis Korea.
Sales of the drug have been temporarily halted from April owing its link to an increased risk of heart attacks and strokes. Previously, the US Food and Drug Administration pulled Zelmac from the American market after a Swiss government analysis of 29 studies.
The Ministry of...
Sales of the drug have been temporarily halted from April owing its link to an increased risk of heart attacks and strokes. Previously, the US Food and Drug Administration pulled Zelmac from the American market after a Swiss government analysis of 29 studies.
The Ministry of...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.